Skip to main content
Agios Pharmaceuticals, Inc. (AGIO)
NASDAQ: AGIO · Real-Time Price · USD
28.53
+1.06 (3.86%)
At close: Mar 9, 2026, 4:00 PM EDT
27.15
-1.38 (-4.84%)
After-hours: Mar 9, 2026, 5:36 PM EDT

Agios Pharmaceuticals Revenue

In the year 2025, Agios Pharmaceuticals had annual revenue of $54.03M with 48.03% growth. Agios Pharmaceuticals had revenue of $19.97M in the quarter ending December 31, 2025, with 86.09% growth.

Revenue (ttm)
$54.03M
Revenue Growth
+48.03%
P/S Ratio
30.94
Revenue / Employee
$100,052
Employees
540
Market Cap
1.67B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202554.03M17.53M48.03%
Dec 31, 202436.50M9.68M36.07%
Dec 31, 202326.82M12.58M88.36%
Dec 31, 202214.24M--
Dec 31, 2021---
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Novavax 1.12B
Harmony Biosciences Holdings 868.45M
Innoviva 411.33M
Immunocore Holdings 400.02M
AnaptysBio 234.60M
Intellia Therapeutics 67.67M
Nuvation Bio 62.90M
Revenue Rankings

AGIO News

More News